No full marketing authorisation yet for Covishield and Covaxin vaccines

Review process to continue, experts studying data submitted

There is still some time till Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin get full marketing authorisation from India’s drug regulator.

According to government sources, the review process is underway and experts are studying the data in detail. Moreover, the vaccine makers are keen to start selling the vaccines in retail pharmacies once they get full marketing approval. The Centre, however, is unlikely to allow that until the pandemic ends.

“The review process is on and will continue. It takes time to study and analyse the huge amounts of data generated and submitted,” said the source who is close to